This reply
Lopi mark this message contains misinformation
originally written by Lopi
1⃣️原文引用的報導來自中央通訊社《Taiwan's CDC to publish Medigen COVID-19 research in U.S. journal》,參考[1].報導中提到這是台灣衛生機構對台灣兩千三百萬人 施打六千萬劑上市疫苗注射後的成效和副作用追蹤,《醫學上屬於疫苗上市後的第四期人體試驗》。
2⃣️報導中並沒有提到美國的CDC認可高端疫苗,高端疫苗沒有經過第三期試驗,不能申請美國CDC緊急使用認證,也不能在美國上市,Po文宣稱“CDC公開並認可國產高端疫苗的數據”,不是事實,此部分為假。
3⃣️此外,論文所用的數據來自最近台灣Omicron的患者,由於Omicron變種以後,威力已經大減,各國紛紛解除大流行(Pandemic),對於Omicron的疫苗研究,已經不那麼重要。

References

[1]中央社 Taiwan's CDC to publish Medigen COVID-19 research in U.S. journal
https://focustaiwan.tw/sci-tech/202402020014

Taiwan's CDC to publish Medigen COVID-19 research in U.S. journal - Focus Taiwan

Taipei, Feb. 2 (CNA) A COVID-19 vaccine research from Taiwan-based Medigen Vaccine Biologics Corp., which found its locally-produced vaccine was as effective as the Moderna and Pfizer BioNTech vaccine

https://focustaiwan.tw/sci-tech/202402020014

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.